Aurobindo Pharma intimates resignation of Dr. Sanjay Chaturvedi as CEO of wholly-owned subsidiary Apitoria Pharma.
Resignation effective close of business hours on May 4, 2026, citing move to different opportunity.
Regulatory disclosure filed with NSE and BSE regarding management change in pharmaceutical subsidiary.